Environment and systemic lupus erythematosus.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
05 2024
Historique:
received: 29 02 2024
accepted: 22 04 2024
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 14 5 2024
Statut: ppublish

Résumé

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of clinical manifestations and a relapsing-remitting course. SLE pathogenesis is the result of complex interactions between ethnic, genetic, epigenetic, immunoregulatory, hormonal and environmental factors, and several aspects of these multifactorial connections are still unclear. Overall, for the disease development, an environmental trigger may induce immunological dysfunction in genetically predisposed individuals. This review aims to summarise the most relevant data on the impact of environmental factors on the incidence of SLE and on disease activity and damage in patients with an established diagnosis of SLE.

Identifiants

pubmed: 38743446
pii: 20971
doi: 10.55563/clinexprheumatol/17vmqc
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1104-1114

Auteurs

Chiara Cardelli (C)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, and Department of Medical Biotechnologies, University of Siena, Italy.

Dina Zucchi (D)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, and Department of Medical Biotechnologies, University of Siena, Italy.

Elena Elefante (E)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Viola Signorini (V)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Marina Menchini (M)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Chiara Stagnaro (C)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Marta Mosca (M)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Chiara Tani (C)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. chiara.tani@unipi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH